Cytosorbents Corp Company Profile (OTCMKTS:CTSO)

Analyst Ratings

Consensus Ratings for Cytosorbents Corp (OTCMKTS:CTSO) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.00

Analysts' Ratings History for Cytosorbents Corp (OTCMKTS:CTSO)
Show:
DateFirmActionRatingPrice TargetActions
7/17/2016Maxim GroupReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2015WBB SecuritiesUpgradeSpeculative Buy -> Buy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015MLV & Co.Lower Price TargetBuy$28.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Cytosorbents Corp (OTCMKTS:CTSO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/11/2016        
5/9/2016Q116($0.10)($0.08)$1.73 million$1.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.08)($0.08)$1.58 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2015Q315($0.10)($0.11)$1.26 million$1.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2015Q215($0.11)$0.05$1.69 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115($0.13)($0.11)$724.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2014($0.01)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014($0.01)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/31/2014($0.01)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cytosorbents Corp (OTCMKTS:CTSO)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cytosorbents Corp (OTCMKTS:CTSO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cytosorbents Corp (OTCMKTS:CTSO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/7/2016Michael G BatorDirectorBuy3,000$4.88$14,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Vincent CapponiCOOSell4,000$7.50$30,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2015Al KrausDirectorSell6,774$6.22$42,134.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2015Al KrausDirectorSell10,000$6.39$63,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015Al KrausDirectorSell10,000$6.26$62,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2015Al KrausDirectorSell10,000$6.44$64,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015Al KrausDirectorSell10,000$6.64$66,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2015Al KrausDirectorSell10,000$7.26$72,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015Al KrausDirectorSell10,000$7.26$72,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2015Al KrausDirectorSell10,000$6.39$63,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2015Al KrausDirectorSell10,000$7.26$72,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Al KrausDirectorSell10,000$6.26$62,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2015Al KrausDirectorSell10,000$6.28$62,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2015Al KrausDirectorSell10,000$6.33$63,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2015Al KrausDirectorSell10,000$5.98$59,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2015Al KrausDirectorSell10,000$6.29$62,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2015Al KrausDirectorSell13,205$7.33$96,792.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Al KrausDirectorSell10,000$5.78$57,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2015Al KrausDirectorSell10,000$6.29$62,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Al KrausDirectorSell10,000$6.30$63,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Al KrausDirectorSell10,000$6.32$63,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014Al KrausDirectorSell100,000$0.24$24,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/10/2014James T GuntonDirectorSell1,240,762$0.24$297,782.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2014Al KrausDirectorSell41,500$0.23$9,545.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014Al KrausDirectorSell8,500$0.23$1,955.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014James T GuntonDirectorSell30,450$0.24$7,308.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014James T GuntonDirectorSell100,000$0.24$24,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Al KrausDirectorSell50,000$0.25$12,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Kathleen P BlochCFOBuy65,000$0.23$14,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2014James T GuntonDirectorSell214,387$0.24$51,452.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014James T GuntonDirectorSell1,360,000$0.24$326,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Al KrausDirectorSell100,000$0.25$25,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Al KrausDirectorSell100,000$0.27$27,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Al KrausDirectorSell100,000$0.28$28,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2014Kathleen P BlochCFOBuy110,000$0.24$26,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012Phillip P ChanCEOBuy190,000$0.13$24,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cytosorbents Corp (OTCMKTS:CTSO)
DateHeadline
07/21/16 03:38 PMEquity Roundup: Stock Performance Focus on Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph
07/20/16 10:48 PMIt Seems Cytosorbents Corp Will Go Up. Have Another Big Increase - Consumer Eagle
07/20/16 10:48 PMCytosorbents Corporation (NASDAQ:CTSO) Shorts Decreased by 2.44% After Short Covering - Press Telegraph
07/18/16 03:02 PMCytosorbents Corporation Stock Momentum at Critical Inflection Point - CML News
07/18/16 03:02 PMCytosorbents Corp (NASDAQ:CTSO) Sentiment Drops in 2016 Q1 - Press Telegraph
07/15/16 08:13 AMCytosorbents Corporation (NASDAQ:CTSO) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 08:13 AMAnalyst Target and Average Rating Watch: Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph
07/14/16 04:08 PM7.13.16 Medial and Meditrade Bring CytoSorb to Hungary, Czech Republic, Slovakia and Poland - [at noodls] - c9c8da3d-d2c3-4869-b853-26d34ef673c2.pdf CytoSorbents Teams with Medial and Meditrade to Bring CytoSorb® to Hungary, Czech Republic, Slovakia, and Poland MONMOUTH JUNCTION, N.J., July 13, 2016 - CytoSorbents ...
07/14/16 04:08 PM7.6.16 CytoSorbents To Presents at Cantor Fitzgerald Healthcare Conference - [at noodls] - af07eba9-d18d-4f02-a531-668a05c03d7f.pdf CytoSorbents to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference MONMOUTH JUNCTION, NJ - July 6, 2016 - CytoSorbents Corporation (NASDAQ: CTSO), ...
07/14/16 03:43 PMTrading Performance and Target Watch for Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph
07/14/16 06:37 AMCytosorbents Corporation (NASDAQ:CTSO) Shorted Shares Decreased By 0.72% - Consumer Eagle
07/13/16 03:35 PMCytosorbents Corporation (NASDAQ:CTSO) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 07:00 AMCytoSorbents Teams with Medial and Meditrade to Bring CytoSorb® to Hungary, Czech Republic, Slovakia, and Poland - [PR Newswire] - MONMOUTH JUNCTION, N.J., July 13, 2016 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly ...
07/12/16 03:37 PMOption Market: Cytosorbents Corporation Risk Hits An Elevated Level - CML News
07/11/16 08:17 AMStock Rating Watch and Earnings Insight for Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph
07/10/16 08:04 AMCytosorbents Corporation (NASDAQ:CTSO) Sellers Covered 0.72% of Their Shorts - Press Telegraph
07/08/16 10:51 PM7.1.16 CytoSorbents Closes $10M Debt Financing with Bridge Bank - [at noodls] - 1a6f93c3-838e-4db7-9b38-04eee66e341d.pdf CytoSorbents Closes $10 Million Debt Financing with Bridge Bank MONMOUTH JUNCTION, N.J, July 1, 2016 - CytoSorbents Corporation (NASDAQ: CTSO), a critical care ...
07/08/16 10:51 PM6.22.16 CytoSorbents Awarded $150K Universal Plasma Phase I STTR - [at noodls] - 98f29b3a-dc58-4d32-88fe-90539ff2aa57.pdf CytoSorbents Awarded $150,000 Phase I STTR Contract for Universal Plasma Development MONMOUTH JUNCTION, NJ - June 22, 2016 - CytoSorbents Corporation (NASDAQ: CTSO), ...
07/08/16 10:51 PM6.13.16 CytoSorbents and Palex Bring CytoSorb to Spain and Portugal - [at noodls] - 4f07b41e-3399-4f94-800f-ba7158d352d5.pdf CytoSorbents and Palex Bring CytoSorb® to Spain and Portugal MONMOUTH JUNCTION, N.J., June 13, 2016 - CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy ...
07/08/16 03:30 PMCan Cytosorbents Corporation (NASDAQ:CTSO) Improve on the Earnings Front? - Engelwood Daily
07/08/16 03:30 PMCompany Stock Focus for Cytosorbents Corporation (NASDAQ:CTSO): Which Way Will Shares Head? - Press Telegraph
07/07/16 09:08 AMCytoSorbents' blood filter is saving lives and money
07/06/16 08:12 AMCytosorbents Corporation (NASDAQ:CTSO) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/06/16 08:12 AMShare Performance Recap for: Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph
07/06/16 06:00 AMCytoSorbents to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference - [PR Newswire] - MONMOUTH JUNCTION, N.J., July 6, 2016 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification filter to treat deadly ...
07/01/16 06:21 AMCYTOSORBENTS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements -
07/01/16 06:00 AMCytoSorbents Closes $10 Million Debt Financing with Bridge Bank - [PR Newswire] - MONMOUTH JUNCTION, N.J., July 1, 2016 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood purification cartridge to prevent or treat deadly inflammation and organ failure in critically-ill and cardiac surgery patients around the world, announced that it has closed upon a $10 million senior debt facility with the Life Sciences Group of Bridge Bank, a division of Western Alliance Bank (WAL).
06/30/16 03:43 PMEquity Research and Technical Review on Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph
06/30/16 09:46 AMCytosorbents Corporation (NASDAQ:CTSO) Sellers Covered 0.72% of Their Shorts - Engelwood Daily
06/29/16 08:29 PMCytosorbents Corporation (NASDAQ:CTSO) Company Rating and Target Watch - Telanagana Press
06/27/16 03:29 PMShare Update and Earnings Review for Cytosorbents Corporation (NASDAQ:CTSO) - Press Telegraph
06/25/16 07:20 AMCytosorbents Corporation (NASDAQ:CTSO) Earnings Glance and Target Price Review - Engelwood Daily
06/25/16 07:20 AMCovering the Bases on Cytosorbents Corporation (NASDAQ:CTSO): Where is the Stock Going? - Press Telegraph
06/22/16 08:00 AMCytoSorbents Awarded $150,000 Phase I STTR Contract for Universal Plasma Development - [PR Newswire] - MONMOUTH JUNCTION, N.J., June 22, 2016 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that it was awarded ...
06/20/16 01:17 PMETF’s with exposure to CytoSorbents Corp. : June 20, 2016 -
06/13/16 07:30 AMCytoSorbents and Palex Bring CytoSorb® to Spain and Portugal - [PR Newswire] - MONMOUTH JUNCTION, N.J., June 13, 2016 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that it has signed an exclusive distributorship agreement with Palex Medical SA, one of Spain's largest independent medical device distributors, to bring its CytoSorb® therapy to Spain and Portugal. This multi-year agreement includes all critical care applications in these two countries, and is subject to annual minimum purchases of CytoSorb® to maintain exclusivity.
06/10/16 05:03 AMCYTOSORBENTS CORP Files SEC form 8-K, Change in Directors or Principal Officers -
06/08/16 01:12 PMCYTOSORBENTS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/03/16 10:59 AMCytosorbents Corp (CTSO) Stock Rating Reaffirmed by Maxim Group - Let Me Know About This
06/03/16 09:30 AMCTSO: Fresenius Commences Sales, DSMB Recommends Continuation of REFRESH I -
06/02/16 09:29 PMShare Rating Focus on Cytosorbents Corporation (NASDAQ:CTSO) - HNN - Share Rating Focus on Cytosorbents Corporation (NASDAQ:CTSO)HNNThis stock research may entail following what professional equity analysts think about the company. Presently, Wall Street analysts have given a consensus stock rating of 1.2 on shares of Cytosorbents Corporation (NASDAQ:CTSO). Covering analysts will ...and more »
06/02/16 10:28 AMTarget Price and Stock Performance Rundown for Cytosorbents Corporation (NASDAQ:CTSO) - HNN - Target Price and Stock Performance Rundown for Cytosorbents Corporation (NASDAQ:CTSO)HNNDuring the latest trading session, Cytosorbents Corporation (NASDAQ:CTSO) shares traded +4.43%. Monitoring the stock price relative to moving averages may offer enhanced perspective on stock performance. After a recent check, shares have been seen ...and more »
06/01/16 04:55 PM5.27.16 CytoSorbents: DSMB Recommends Continuation of REFRESH I Trial - [at noodls] - ef13270c-80d5-4f87-8254-6595e1fd631b.pdf Independent Data Safety Monitoring Board Recommends Continuation of CytoSorbents REFRESH I Trial MONMOUTH JUNCTION, NJ - May 27, 2016 - CytoSorbents Corporation ...
06/01/16 10:33 AMCytoSorbents Announces Fresenius Medical Care Initiates Sales of CytoSorb® in France, Poland and Scandinavia - PR Newswire (press release) - CytoSorbents Announces Fresenius Medical Care Initiates Sales of CytoSorb® in France, Poland and ScandinaviaPR Newswire (press release)MONMOUTH JUNCTION, N.J., June 1, 2016 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood purification cartridge to prevent or treat deadly inflammation and ...and more »
06/01/16 06:00 AMCytoSorbents Announces Fresenius Medical Care Initiates Sales of CytoSorb® in France, Poland and Scandinavia - [PR Newswire] - MONMOUTH JUNCTION, N.J., June 1, 2016 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood purification cartridge to prevent or treat deadly inflammation and organ failure in critically-ill and cardiac surgery patients around the world, announced that Fresenius Medical Care (FMC), its strategic partner for acute care indications in France, Poland, Sweden, Denmark, Finland, and Norway, has officially initiated its CytoSorb® sales efforts. As part of its acute care business, Fresenius Medical Care has deployed a commercial team of sales, marketing, and medical experts to drive sales of CytoSorb®. This team, which is highly experienced and actively sells Fresenius' products into intensive care units, has been trained and is leading CytoSorb® marketing and sales efforts throughout the territory.
05/30/16 07:16 AM8:16 am CytoSorbents indicated higher after Independent Data Safety Monitoring Board recommends continuation of CytoSorbents REFRESH I trial -
05/27/16 07:00 AMIndependent Data Safety Monitoring Board Recommends Continuation of CytoSorbents REFRESH I Trial - [PR Newswire] - MONMOUTH JUNCTION, N.J., May 27, 2016 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood purification cartridge to prevent or treat deadly inflammation and organ failure in critically-ill and cardiac surgery patients around the world, announced that the independent Data Safety Monitoring Board (DSMB) of the current U.S. REFRESH I cardiac surgery trial positively evaluated the safety data from the first 24 patients in a scheduled meeting, found no safety concerns, and recommended continuation of the trial to completion without changes. REFRESH (REduction in FREe Hemoglobin) I is a company-sponsored 40-patient, multi-center, randomized, controlled safety and feasibility study using CytoSorb® intra-operatively during elective, non-emergent complex cardiac surgery where cardiopulmonary bypass is expected to last longer than 3 hours.
05/26/16 07:47 AMTarget Check and Stock Performance Recap Cytosorbents Corporation (NASDAQ:CTSO) - Wall Street Hints and News - Target Check and Stock Performance Recap Cytosorbents Corporation (NASDAQ:CTSO)Wall Street Hints and NewsIn recent session activity, Cytosorbents Corporation (NASDAQ:CTSO) shares have traded -1.68%. Monitoring the stock price relative to moving averages may provide enhanced perspective on share performance. After a recent check, the stock has been ...and more »
03/14/16 01:48 PMAnalysts Speculate on Two Biotech Stocks: Anavex Life Sciences Corp. (AVXL) and Cytosorbents Corp (CTSO) - Smarter Analyst - Smarter AnalystAnalysts Speculate on Two Biotech Stocks: Anavex Life Sciences Corp. (AVXL) and Cytosorbents Corp (CTSO)Smarter AnalystOptimistic views on Alzheimer remedy in its making by Anavex Life Sciences Corp (NYSE:AVXL) and improved earnings report by Cytosorbents Corp (NASDAQ:CTSO) caused analysts to reiterate Buy ratings on both companies. Let's take a closer look:.and more »
03/14/16 10:45 AMCytoSorbents Corp. :CTSO-US: Earnings Analysis: Q4, 2015 By the Numbers -

Social

About Cytosorbents Corp

Cytosorbents Corp logoCytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company's CytoSorb is an extracorporeal cytokine filter and is designed to reduce the cytokine storm that causes inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury and pancreatitis. In addition, CytoSorb is used in other inflammatory conditions, such as cardiac surgery and autoimmune disease flares and cancer cachexia. It also has other products under development based upon its blood purification technology, including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: CTSO
  • CUSIP:
Key Metrics:
  • Previous Close: $4.62
  • 50 Day Moving Average: $4.61
  • 200 Day Moving Average: $4.39
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $117.39M
  • Current Year EPS Consensus Estimate: $-0.35 EPS
  • Next Year EPS Consensus Estimate: $-0.27 EPS
Additional Links:
Cytosorbents Corp (OTCMKTS:CTSO) Chart for Sunday, July, 24, 2016